~ Xencor, Inc., of Monrovia, a clinical-stage biopharmaceutical company, has received a payment from Merck, through a subsidiary, for beginning a Phase 1 clinical trial for a biologic drug candidate that uses Xencor's XmAb antibody engineering. http://goo.gl/z8fZZK
~ Assembly Bill AB 1970, by Monrovia's assembly member, Chris Holden, to establish a grant program encouraging school districts to provide more Advanced Placement classes in Science, Technology, Engineering and Math, has been approved in the Assembly Education Committee. Source: press release
- Brad Haugaard
No comments:
Post a Comment